Skip to main content
. 2023 Sep 4;24(10):e56724. doi: 10.15252/embr.202256724

Figure EV4. Centrosomes or CEP170 loss hyper‐sensitize to treatment with DNA damaging agents.

Figure EV4

Representative images of clonogenic assays shown in Fig 4A–H.